Optimal coronary reflow is the critical key issue to ameliorate clinical outcomes in patients with cardiogenic shock complicating ST-segment elevation myocardial infarction (Shock-STEMI). We investigated our hypothesis that pre-percutaneous coronary…
Previous models for contrast-induced acute kidney injury (CI-AKI) after percutaneous coronary intervention (PCI) include procedure-related variables in addition to pre-procedural variables. We sought to develop a risk model for CI-AKI…
We evaluated the clinical efficacy and cost of a cardiac imaging strategy versus a traditional exercise tolerance test (ETT) strategy for the investigation of suspected stable coronary artery disease (CAD)….
Despite advances in evidence-based treatments, the morbidity and mortality of congestive heart failure remain exceedingly high. In addition, the costs associated with recurrent hospitalizations and advanced therapies, such as implantable…
In recent years, there has been an increased emphasis on the diagnosis and treatment of valvular heart disease and, in particular, aortic stenosis. This has been driven in part by…
The corrected affiliation information for the two authors (Ondrej Sochor and Quinn Pack) with previously incorrect affiliation information is shown below. For first author, Ondrej Sochor: Division of Cardiovascular Diseases,…
In the abstract and Table 2, the adjusted hazard ratio is not correct. The correct adjusted hazard ratio is 1.18 (95% CI 0.75 to 1.84), p = 0.47.
Several blood biomarkers have been identified which are helpful in supporting atrial fibrillation (AF) diagnosis, prognosis, and outcomes. Because of its involvement in cardiac fibrosis, inflammation, and remodeling processes, galectin-3…
We read the recently published study by Clark et al of obesity as a positive prognostic factor in patients with advanced systolic heart failure (obesity paradox). The investigators observed the obesity…
